TGen News & Press Releases

City of Hope, TGen awarded five-year, $4.5 million grant to advance liquid biopsy for pancreatic cancer

Posted Thursday October 26, 2023

New antibody shows strong potential against pancreatic cancer

Posted Thursday October 12, 2023

SIWA318H specifically targets and removes senescent cells in pancreatic tumors, slowing their growth

TGen’s 18th Annual Step-N-Out Scheduled for November 5

Posted Wednesday September 20, 2023

Register Today for TGen’s Annual Event That Kicks Off Pancreatic Cancer Awareness Month

Genome sequencing identifies factors that cause resistance to multiple myeloma T cell therapies

Posted Thursday August 31, 2023

Study suggests the problem is more common than previously thought

Study Links Inherited Mutations to Okur-Chung Neurodevelopmental Syndrome

Posted Wednesday August 16, 2023

HELIOS SCHOLARS AT TGEN CELEBRATE 17th ANNUAL SUMMER OF SCIENCE

Posted Thursday July 27, 2023

Interns Showcase Work at Day-Long Scientific Symposium

TGen appoints J. Gregory Caporaso, Ph.D., Professor in its Pathogen and Microbiome Division

Posted Tuesday July 25, 2023

Erroneous genetic sequences identified for the first time in specific cells of ALS and frontotemporal dementia patients

Posted Wednesday July 19, 2023

Gene splicing defect known as “cryptic exons” detected using single-nuclei RNA sequencing

Novel Genetic Sequencing Technology Helps Researchers Find Answers in Cases of Pediatric Rare Disorders

Posted Monday July 10, 2023

The study identified likely cause of genetic disorder in six families

Single-Cell Atlas of the Whole Human Lung

Posted Thursday June 8, 2023

First integrated Human Lung Cell Atlas provides insights into lung diseases

Prev
1
2
3
[4]
5
Next

Media Contact

Galen Perry
[email protected]
602-343-8423

Newsletter

News Archive

View Media Release Archive

OnCline

TGen is a partner with OncLive

2024 © All Rights Reserved TGen. Registered 501(c)(3). EIN: 75-3065445